Opioids have quickly emerged as one of the primary means for managing acute and chronic non‐cancer pain in primary care settings. With an estimated 2,000 Canadians dying annually from prescription opioids, it is clear that we are facing a national crisis. Currently, Canada is the second highest consumer of prescription opioids in the world, with available evidence pointing to back pain and other musculoskeletal (MSK) conditions as one of the key drivers.

What is clear is that change is needed to prioritize safer alternatives for Canadians struggling with chronic pain. As experts in musculoskeletal health, Canada’s chiropractors can play a bigger role in reducing over-reliance of opioids, starting with the conservative management of MSK conditions.

The CCA has been advocating on behalf of Canadian chiropractors and their patients for greater access to conservative care options as first-line treatment of MSK conditions. By providing prompt access to clinical alternatives, like chiropractic care, evidence suggests that we can reduce reliance on opioids to treat acute and chronic MSK-related pain. As part of the CCA’s participation in the federal Minister of Health’s National Opioid Conference and Summit on November 18 and 19, 2016, the CCA has outlined the profession’s position on the need for greater access to alternatives to opioids as first-line treatment, especially for those suffering from back pain and other MSK conditions. Together we can support and facilitate progressive and innovative practices that will not only improve health outcomes but also decrease over-reliance on opioids as a first-line intervention.

Read the White Paper HERE